Revenue Breakdown
Composition ()
No data
Revenue Streams
Core Laboratories Inc (CLB) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Service, accounting for 73.9% of total sales, equivalent to $96.22M. Another important revenue stream is Product sales. Understanding this composition is critical for investors evaluating how CLB navigates market cycles within the Business Support Services industry.
Profitability & Margins
Evaluating the bottom line, Core Laboratories Inc maintains a gross margin of 19.35%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 15.71%, while the net margin is 10.80%. These profitability ratios, combined with a Return on Equity (ROE) of 12.31%, provide a clear picture of how effectively CLB converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, CLB competes directly with industry leaders such as VTS and OBE. With a market capitalization of $916.95M, it holds a leading position in the sector. When comparing efficiency, CLB's gross margin of 19.35% stands against VTS's 12.65% and OBE's 34.83%. Such benchmarking helps identify whether Core Laboratories Inc is trading at a premium or discount relative to its financial performance.
